Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus—A Prospect
AbstractAn increasing prevalence of diabetes is known as a main risk for human health in the last future worldwide. There is limited evidence on the potential management of type 2 diabetes mellitus using bioactive peptides from marine organisms, besides from milk and beans. We summarized here recent advances in our understanding of the regulation of glucose metabolism using bioactive peptides from natural proteins, including regulation of insulin-regulated glucose metabolism, such as protection and reparation of pancreatic β-cells, enhancing glucose-stimulated insulin secretion and influencing the sensitivity of insulin and the signaling pathways, and inhibition of bioactive peptides to dipeptidyl peptidase IV, α-amylase and α-glucosidase activities. The present paper tried to understand the underlying mechanism involved and the structure characteristics of bioactive peptides responsible for its antidiabetic activities to prospect the utilization of rich marine organism proteins. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Xia, E.-Q.; Zhu, S.-S.; He, M.-J.; Luo, F.; Fu, C.-Z.; Zou, T.-B. Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus—A Prospect. Mar. Drugs 2017, 15, 88.
Xia E-Q, Zhu S-S, He M-J, Luo F, Fu C-Z, Zou T-B. Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus—A Prospect. Marine Drugs. 2017; 15(4):88.Chicago/Turabian Style
Xia, En-Qin; Zhu, Shan-Shan; He, Min-Jing; Luo, Fei; Fu, Cheng-Zhan; Zou, Tang-Bin. 2017. "Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus—A Prospect." Mar. Drugs 15, no. 4: 88.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.